These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28807905)

  • 21. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
    Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Whole-Body Physiologically Based Pharmacokinetic Model for Colistin and Colistin Methanesulfonate in Rat.
    Bouchene S; Marchand S; Couet W; Friberg LE; Gobin P; Lamarche I; Grégoire N; Björkman S; Karlsson MO
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):407-422. PubMed ID: 29665289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrapulmonary and Systemic Pharmacokinetics of Colistin Following Nebulization of Low-Dose Colistimethate Sodium in Patients with Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant
    Lee DH; Kim SY; Kim YK; Jung SY; Jang JH; Jang HJ; Lee JH
    Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
    Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
    J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.
    Gontijo AV; Brillault J; Grégoire N; Lamarche I; Gobin P; Couet W; Marchand S
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3942-9. PubMed ID: 24798283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.
    Marchand S; Bouchene S; de Monte M; Guilleminault L; Montharu J; Cabrera M; Grégoire N; Gobin P; Diot P; Couet W; Vecellio L
    Pharm Res; 2015 Oct; 32(10):3403-14. PubMed ID: 26040660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.
    Stass H; Nagelschmitz J; Kappeler D; Sommerer K; Kietzig C; Weimann B
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):53-63. PubMed ID: 27448179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of diluent volume of colistimethate sodium on aerosol characteristics and pharmacokinetics in ventilator-associated pneumonia caused by MDR bacteria.
    Bihan K; Zahr N; Becquemin MH; Lu X; Bertholon JF; Vezinet C; Arbelot C; Monsel A; Rouby JJ; Langeron O; Lu Q
    J Antimicrob Chemother; 2018 Jun; 73(6):1639-1646. PubMed ID: 29506194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New aerosol formulation to control ciprofloxacin pulmonary concentration.
    Lamy B; Tewes F; Serrano DR; Lamarche I; Gobin P; Couet W; Healy AM; Marchand S
    J Control Release; 2018 Feb; 271():118-126. PubMed ID: 29277683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.
    Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG
    J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients.
    Boisson M; Mimoz O; Hadzic M; Marchand S; Adier C; Couet W; Grégoire N
    J Antimicrob Chemother; 2018 Oct; 73(10):2830-2837. PubMed ID: 29947799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study.
    Stass H; Delesen H; Nagelschmitz J; Staab D
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):106-15. PubMed ID: 25050456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High azithromycin loading powders for inhalation and their in vivo evaluation in rats.
    Zhang Y; Wang X; Lin X; Liu X; Tian B; Tang X
    Int J Pharm; 2010 Aug; 395(1-2):205-14. PubMed ID: 20595022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery.
    Tewes F; Brillault J; Gregoire N; Olivier JC; Lamarche I; Adier C; Healy AM; Marchand S
    Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32560289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats. 4. Aztreonam.
    Marchand S; Grégoire N; Brillault J; Lamarche I; Gobin P; Couet W
    Antimicrob Agents Chemother; 2016 May; 60(5):3196-8. PubMed ID: 26926626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
    Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
    Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of plasma and pulmonary availability of chlorogenic acid, forsythiaside A and baicalin after intratracheal and intravenous administration of Shuang-Huang-Lian injection.
    Wei-Ya C; Fei-Fei Y; Cui L; Wen-Hui L; Jie H; Yong-Hong L
    J Ethnopharmacol; 2021 Jun; 274():114082. PubMed ID: 33813012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
    Jacobs M; Grégoire N; Mégarbane B; Gobin P; Balayn D; Marchand S; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1788-93. PubMed ID: 26729492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.